Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
Conditions : COVID-19; COVID-19 (SARS-CoV-2 Infection) Interventions : Biological: LB-DTK-COV19 Sponsors : LucasBio Active, not recruiting
Read the full article2d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Qualitative Study Protocol on Ethical Perceptions of Simulative Technologies in Long-Term Dementia Care
doi.org·45m agoAI predicts late breast cancer recurrence risk
yesilscience.com·1h ago
AI Medicare Denials Are Here to Stay
yesilscience.com·5h ago
A blind woman reached out and touched a tree she couldn’t see. She’d ‘heard’ it standing there.
Upworthy·6h ago
Leafy Greens May Cut COPD Risk by 16%, Large UK Study Finds
Science Sensei·6h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.